Anna Sicuranza
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 26
- Chronic Myeloid Leukemia Treatments 15
- Multiple Myeloma Research and Treatments 12
- Acute Myeloid Leukemia Research 8
- Genetics 19
- Chronic Lymphocytic Leukemia Research 14
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Monica Bocchia (37 shared papers)Emanuele Cencini (15 shared papers)Alessandro Gozzetti (19 shared papers)Donatella Raspadori (25 shared papers)Alberto Fabbri (7 shared papers)Marzia Defina (11 shared papers)Claudia Baratè (6 shared papers)Elisabetta Zappone (5 shared papers)
In The Last Decade
Anna Sicuranza
37 papers receiving 308 citations
Peers
Comparison fields: 5 of 48
- Hematology 137
- Genetics 67
- Immunology 65
- Oncology 77
- Infectious Diseases 52
Countries citing papers authored by Anna Sicuranza
This map shows the geographic impact of Anna Sicuranza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sicuranza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sicuranza more than expected).
Fields of papers citing papers by Anna Sicuranza
This network shows the impact of papers produced by Anna Sicuranza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sicuranza. The network helps show where Anna Sicuranza may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Sicuranza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 42 | |
| 2 | 2020 | 22 | |
| 3 | 2016 | 22 | |
| 4 | 2021 | 20 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 17 | |
| 7 | 2023 | 17 | |
| 8 | 2020 | 16 | |
| 9 | 2022 | 15 | |
| 10 | 2020 | 12 | |
| 11 | 2018 | 12 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2023 | 9 | |
| 15 | Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma. | 2020 | 9 |
| 16 | 2010 | 8 | |
| 17 | 2014 | 7 | |
| 18 | 2013 | 6 | |
| 19 | 2010 | 6 | |
| 20 | 2025 | 3 |
About Anna Sicuranza
Anna Sicuranza is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Oncology, having authored 43 papers that have together received 309 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (14 papers), Multiple Myeloma Research and Treatments (12 papers), Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Hematology (137 citations), Genetics (67 citations), Immunology (65 citations), Oncology (77 citations) and Infectious Diseases (52 citations). Anna Sicuranza has collaborated with scholars based in Italy, Ireland and France. Frequent co-authors include Monica Bocchia, Emanuele Cencini, Alessandro Gozzetti, Donatella Raspadori, Alberto Fabbri, Marzia Defina, Claudia Baratè, Elisabetta Zappone, Elisabetta Abruzzese and Lara Aprile. Their work appears in journals such as Blood, Cancers, Frontiers in Oncology, Pharmaceuticals and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.